{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T05:00:54Z","timestamp":1791608454088,"version":"4.3.4"},"reference-count":295,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LZ23H030002"],"award-info":[{"award-number":["LZ23H030002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104277"],"award-info":[{"award-number":["82104277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M733080"],"award-info":[{"award-number":["2023M733080"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020777","name":"Zhejiang Pharmaceutical Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020777","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.drup.2025.101225","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T11:27:57Z","timestamp":1741174077000},"page":"101225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Methotrexate resistance and its regulatory mechanisms in pediatric tumors and beyond"],"prefix":"10.1016","volume":"81","author":[{"given":"Jing","family":"Nie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lantian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongai","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jufei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2025.101225_bib1","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1002\/cam4.2982","article-title":"Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity","volume":"9","author":"Abedi","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.drup.2025.101225_bib2","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.2147\/OTT.S140488","article-title":"The translational expression of ABCA2 and ABCA3 is a strong prognostic biomarker for multidrug resistance in pediatric acute lymphoblastic leukemia","author":"Aberuyi","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.drup.2025.101225_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s40364-024-00676-9","article-title":"From regulation to deregulation of p53 in hematologic malignancies: implications for diagnosis, prognosis and therapy","volume":"12","author":"Ahmadi","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.drup.2025.101225_bib4","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.2147\/IJN.S133034","article-title":"Liposomal formulation of a methotrexate lipophilic prodrug: assessment in tumor cells and mouse T-cell leukemic lymphoma","author":"Alekseeva","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.drup.2025.101225_bib5","first-page":"S397","article-title":"The concise guide to pharmacology 2019\/20: transporters","volume":"176","author":"Alexander","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drup.2025.101225_bib6","unstructured":"C. Allegra and B.A. Chabner, Antifolates in Cancer Chemotherapy: Principles and Practice, (1990)."},{"key":"10.1016\/j.drup.2025.101225_bib7","first-page":"1383","article-title":"Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia","volume":"114","author":"Ansari","year":"2009","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"10.1016\/j.drup.2025.101225_bib8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/PAS.0000000000000404","article-title":"Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement","volume":"39","author":"Antonescu","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.drup.2025.101225_bib9","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1080\/07391102.2016.1186560","article-title":"Human dihydrofolate reductase and thymidylate synthase form a complex in vitro and co-localize in normal and cancer cells","volume":"35","author":"Antosiewicz","year":"2017","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.drup.2025.101225_bib10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.drup.2006.09.001","article-title":"The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis","volume":"9","author":"Assaraf","year":"2006","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.drup.2025.101225_bib11","first-page":"874","article-title":"Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404)","volume":"118","author":"Asselin","year":"2011","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.drup.2025.101225_bib12","first-page":"185","article-title":"Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma","volume":"128","author":"Assouline","year":"2016","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.drup.2025.101225_bib13","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3899\/jrheum.160950","article-title":"Relationship between polymorphisms in methotrexate pathway genes and outcome of methotrexate treatment in a cohort of 119 patients with juvenile idiopathic arthritis","volume":"44","author":"Avramovi\u010d","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.drup.2025.101225_bib14","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1091\/mbc.e12-02-0132","article-title":"Collagen\/\u03b21 integrin signaling up-regulates the ABCC1\/MRP-1 transporter in an ERK\/MAPK-dependent manner","volume":"23","author":"Azreq","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.drup.2025.101225_bib15","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00432-019-02949-5","article-title":"Ginger extract has anti-leukemia and anti-drug resistant effects on malignant cells","volume":"145","author":"Babasheikhali","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2024.101974","article-title":"Pharmacogenetics of therapies in rheumatoid arthritis: An update","volume":"38","author":"Babiker-Mohamed","year":"2024","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.drup.2025.101225_bib17","article-title":"Glioblastoma progression is inhibited by methotrexate via. RAS\/MEK\/ERK\/MYC\/CD47 signaling pathways","author":"Bai","year":"2018","journal-title":"Electron. J. Metab. Nutr. Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib18","doi-asserted-by":"crossref","first-page":"e1777","DOI":"10.1634\/theoncologist.2020-0352","article-title":"The activity of chemotherapy in inflammatory myofibroblastic tumors: a multicenter, european retrospective case series analysis","volume":"25","author":"Baldi","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.drup.2025.101225_bib19","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.e22545","article-title":"Activity of chemotherapy in inflammatory myofibroblastic tumor (IMT): a retrospective analysis within the Italian Rare Tumours Network (RTR)","volume":"37","author":"Baldi","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/1078-0432.CCR-08-0132","article-title":"Heat shock protein 90 as a drug target: some like it hot","volume":"15","author":"Banerji","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101225_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103337","article-title":"A comprehensive overview of juvenile idiopathic arthritis: from pathophysiology to management","volume":"22","author":"Bansal","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.drup.2025.101225_bib22","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199411103311902","article-title":"Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission","volume":"331","author":"Barrett","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101225_bib23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/pbc.20635","article-title":"ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t (17; 19) and E2A-HLF expression","volume":"47","author":"Baudis","year":"2006","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153176","article-title":"miR-192 enhances sensitivity of methotrexate drug to MG-63 osteosarcoma cancer cells","volume":"216","author":"Bazavar","year":"2020","journal-title":"Pathol. -Res. Pract."},{"key":"10.1016\/j.drup.2025.101225_bib25","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.3390\/ijms20205023","article-title":"Methotrexate an old drug with new tricks","volume":"20","author":"Bedoui","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2025.101225_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1200\/JCO.1990.8.2.193","article-title":"Leucovorin rescue revisited","volume":"8","author":"Bertino","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib27","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.jpedsurg.2011.01.007","article-title":"Unresectable multifocal omental and peritoneal inflammatory myofibroblastic tumor in a child: revisiting the role of adjuvant therapy","volume":"46","author":"Bertocchini","year":"2011","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.drup.2025.101225_bib28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1200\/JCO.2008.18.1487","article-title":"Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group","volume":"27","author":"Brugi\u00e8res","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib29","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/bmj.2.5161.1210","article-title":"Methotrexate in treatment of metastasizing chorioncarcinoma","volume":"2","author":"Buckle","year":"1959","journal-title":"Br. Med. J."},{"key":"10.1016\/j.drup.2025.101225_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/leu.2010.245","article-title":"Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols","volume":"25","author":"Burkhardt","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.drup.2025.101225_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.370","article-title":"ERK\/Drp1-dependent mitochondrial fission is involved in the MSC-induced drug resistance of T-cell acute lymphoblastic leukemia cells","volume":"7","author":"Cai","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101225_bib32","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1182\/blood-2005-03-1024","article-title":"A uniform activated B-cell\u2013like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases","volume":"107","author":"Camilleri-Bro\u00ebt","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.drup.2025.101225_bib33","doi-asserted-by":"crossref","first-page":"1032336","DOI":"10.3389\/fonc.2022.1032336","article-title":"Glutathione levels are associated with methotrexate resistance in acute lymphoblastic leukemia cell lines","volume":"12","author":"Canevarolo","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib34","doi-asserted-by":"crossref","first-page":"1032336","DOI":"10.3389\/fonc.2022.1032336","article-title":"Glutathione levels are associated with methotrexate resistance in acute lymphoblastic leukemia cell lines","volume":"12","author":"Canevarolo","year":"2022","journal-title":"Front. Oncol."},{"issue":"127","key":"10.1016\/j.drup.2025.101225_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejca.2019.12.021","article-title":"Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG)","author":"Casanova","year":"2020","journal-title":"Eur. J. Cancer (Oxf., Engl.: 1990)"},{"key":"10.1016\/j.drup.2025.101225_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1331687","article-title":"Up-regulation of ABCG1 is associated with methotrexate resistance in acute lymphoblastic leukemia cells","volume":"14","author":"Chen","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.drup.2025.101225_bib37","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.7150\/thno.41362","article-title":"PI3K\/AKT inhibition reverses R-CHOP resistance by destabilizing SOX2 in diffuse large B cell lymphoma","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.drup.2025.101225_bib38","first-page":"3144","article-title":"Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4) MRP4 is a component of the methotrexate efflux system","volume":"62","author":"Chen","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101225_bib39","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/bjh.19365","article-title":"High-dose methotrexate pharmacokinetics and its impact on prognosis of paediatric acute lymphoblastic leukaemia patients: a population pharmacokinetic study","volume":"204","author":"Chen","year":"2024","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.drup.2025.101225_bib40","first-page":"4048","article-title":"Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport","volume":"63","author":"Chen","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101225_bib41","article-title":"High-dose methotrexate in pediatric acute lymphoblastic leukemia: predictors of delayed clearance and the effect of increased hydration rate on methotrexate clearance","volume":"12","author":"Chen","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.drup.2025.101225_bib42","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1111\/jcmm.14064","article-title":"Drug resistance-related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies","volume":"23","author":"Chen","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.drup.2025.101225_bib43","first-page":"557","article-title":"A substrate specific functional polymorphism of human \u03b3-glutamyl hydrolase alters catalytic activity and methotrexate polyglutamate accumulation in acute lymphoblastic leukaemia cells","volume":"14","author":"Cheng","year":"2004","journal-title":"Pharm. Genom."},{"key":"10.1016\/j.drup.2025.101225_bib44","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1365-2141.2003.04584.x","article-title":"Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia","volume":"123","author":"Chessells","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.drup.2025.101225_bib45","doi-asserted-by":"crossref","first-page":"9823","DOI":"10.7314\/APJCP.2014.15.22.9823","article-title":"Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience","volume":"15","author":"Choeyprasert","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.drup.2025.101225_bib46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0065-2571(95)00004-6","article-title":"The role of thymidylate synthase in cellular regulation","volume":"36","author":"Chu","year":"1996","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.drup.2025.101225_bib47","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/ijms17060900","article-title":"Rheumatoid arthritis: the stride from research to clinical practice","volume":"17","author":"Chung","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2025.101225_bib48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00280-007-0576-7","article-title":"Phase 2B trial of aminopterin in multiagent therapy for children with newly diagnosed acute lymphoblastic leukemia","volume":"62","author":"Cole","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.drup.2025.101225_bib49","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s12031-020-01561-4","article-title":"Dihydrofolate reductase (DHFR) del19bp polymorphism and down syndrome offspring","volume":"70","author":"Costa-Lima","year":"2020","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.drup.2025.101225_bib50","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/cncr.20152","article-title":"High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma","volume":"100","author":"Crews","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib51","doi-asserted-by":"crossref","first-page":"9647","DOI":"10.2147\/IJN.S205456","article-title":"Preparation and characterization of Fe3O4@ MTX magnetic nanoparticles for thermochemotherapy of primary central nervous system lymphoma in vitro and in vivo","author":"Dai","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.drup.2025.101225_bib52","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.3109\/10428194.2013.784758","article-title":"Influence of methylenetetrahydrofolate reductase gene polymorphisms on the outcome of pediatric patients with non-Hodgkin lymphoma treated with high-dose methotrexate","volume":"54","author":"D'Angelo","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.drup.2025.101225_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/2040620719898373","article-title":"WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma","volume":"11","author":"de Jong","year":"2020","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.drup.2025.101225_bib54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.leukres.2011.10.005","article-title":"Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features","volume":"36","author":"de Oliveira","year":"2012","journal-title":"Leuk. Res."},{"key":"10.1016\/j.drup.2025.101225_bib55","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3899\/jrheum.111593","article-title":"ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis","volume":"39","author":"de Rotte","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.drup.2025.101225_bib56","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1158\/1535-7163.MCT-20-0423","article-title":"Therapeutic targeting of mitochondrial one-carbon metabolism in cancer","volume":"19","author":"Dekhne","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.drup.2025.101225_bib57","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ccell.2018.06.003","article-title":"Structure and mechanisms of NT5C2 mutations driving thiopurine resistance in relapsed lymphoblastic leukemia","volume":"34","author":"Dieck","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101225_bib58","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3324\/haematol.2014.103507","article-title":"Dexamethasone (6 mg\/m2\/day) and prednisolone (60 mg\/m2\/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial","volume":"99","author":"Domenech","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.drup.2025.101225_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40164-020-00170-6","article-title":"Leukemia incidence trends at the global, regional, and national level between 1990 and 2017","volume":"9","author":"Dong","year":"2020","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","article-title":"One-carbon metabolism in health and disease","volume":"25","author":"Ducker","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.drup.2025.101225_bib61","first-page":"3692","article-title":"DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL","volume":"111","author":"Dulucq","year":"2008","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.drup.2025.101225_bib62","first-page":"6069","article-title":"Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma","volume":"113","author":"Dunleavy","year":"2009","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.drup.2025.101225_bib63","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1200\/JCO.2005.01.1031","article-title":"Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87","volume":"23","author":"Einsiedel","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250228","article-title":"Methylene tetrahydrofolate reductase A1298C polymorphisms influence the adult sequelae of chemotherapy in childhood-leukemia survivors","volume":"16","author":"Elens","year":"2021","journal-title":"Plos One"},{"key":"10.1016\/j.drup.2025.101225_bib65","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s12032-011-9997-6","article-title":"Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia","volume":"29","author":"El-Khodary","year":"2012","journal-title":"Med. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib66","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3109\/10428194.2011.639880","article-title":"Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia","volume":"53","author":"Er\u010dulj","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.drup.2025.101225_bib67","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/pbc.24273","article-title":"Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03","volume":"60","author":"Escherich","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib68","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature13236","article-title":"Quantitative flux analysis reveals folate-dependent NADPH production","volume":"510","author":"Fan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101225_bib69","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM194806032382301","article-title":"Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin)","volume":"238","author":"Farber","year":"1948","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101225_bib70","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/(SICI)1096-911X(199712)29:6<534::AID-MPO3>3.0.CO;2-L","article-title":"Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: a study of the children's cancer group (CCG-1884)","volume":"29","author":"Feig","year":"1997","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib71","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12969-018-0255-8","article-title":"Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting","volume":"16","author":"Ferrara","year":"2018","journal-title":"Pedia Rheuma Online J."},{"key":"10.1016\/j.drup.2025.101225_bib72","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2141.2004.05109.x","article-title":"Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas","volume":"126","author":"Ferreri","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.drup.2025.101225_bib73","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/rheumatology\/keaa584","article-title":"Consensus-based recommendations for the management of juvenile systemic sclerosis","volume":"60","author":"Foeldvari","year":"2021","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.drup.2025.101225_bib74","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.3390\/ijms20123021","article-title":"Strategies to overcome resistance mechanisms in T-cell acute lymphoblastic leukemia","volume":"20","author":"Follini","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2025.101225_bib75","unstructured":"S. Forde, Investigating heterogeneity and mechanisms of resistance in paediatric B-cell non-Hodgkin lymphoma. University of Cambridge (2019)."},{"key":"10.1016\/j.drup.2025.101225_bib76","article-title":"Histone deacetylase inhibition enhances the therapeutic effects of methotrexate on primary central nervous system lymphoma","volume":"2","author":"Fujimoto","year":"2020","journal-title":"Neuro-Oncol. Adv."},{"key":"10.1016\/j.drup.2025.101225_bib77","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2603092","article-title":"Overcoming therapeutic resistance of bone sarcomas: overview of the molecular mechanisms and therapeutic targets for bone sarcoma stem cells","volume":"2016","author":"Fujiwara","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.drup.2025.101225_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.701452","article-title":"Population pharmacokinetics of high-dose methotrexate in Chinese pediatric patients with acute lymphoblastic leukemia","volume":"12","author":"Gao","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.drup.2025.101225_bib79","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41375-020-0845-6","article-title":"SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia","volume":"35","author":"Garc\u00eda-Ca\u00f1averas","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.drup.2025.101225_bib80","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.autrev.2015.02.006","article-title":"P-glycoprotein in autoimmune rheumatic diseases","volume":"14","author":"Garc\u00eda-Carrasco","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.drup.2025.101225_bib81","doi-asserted-by":"crossref","first-page":"762","DOI":"10.20517\/cdr.2022.18","article-title":"An overview of resistance to chemotherapy in osteosarcoma and future perspectives","volume":"5","author":"Garcia-Ortega","year":"2022","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.drup.2025.101225_bib82","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0006-291X(88)80559-X","article-title":"Expression of a P-glycoprotein gene is inducible in a multidrug resistant human leukemia cell line","volume":"155","author":"Gekeler","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drup.2025.101225_bib83","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/1389200220666190130161758","article-title":"Clinical implications of methotrexate pharmacogenetics in childhood acute lymphoblastic leukaemia","volume":"20","author":"Gervasini","year":"2019","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.drup.2025.101225_bib84","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/jjco\/hyaa025","article-title":"Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL","volume":"50","author":"Ghodousi","year":"2020","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib85","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1002\/jcb.26800","article-title":"MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia","volume":"119","author":"Ghodousi","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.drup.2025.101225_bib86","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","article-title":"Methotrexate in resistant juvenile rheumatoid arthritis: results of the USA\u2013USSR double-blind, placebo-controlled trial","volume":"326","author":"Giannini","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101225_bib87","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/jcpt.13505","article-title":"Association of MTHFR and ABCB1 polymorphisms with MTX-induced mucositis in Chinese paediatric patients with acute lymphoblastic leukaemia, lymphoma or osteosarcoma\u2014a retrospective cohort study","volume":"46","author":"Gong","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.drup.2025.101225_bib88","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13075-019-1936-5","article-title":"Higher baseline global leukocyte DNA methylation is associated with MTX non-response in early RA patients","volume":"21","author":"Gosselt","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.drup.2025.101225_bib89","first-page":"372","article-title":"Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia","volume":"15","author":"Gregers","year":"2015","journal-title":"Pharm. J."},{"key":"10.1016\/j.drup.2025.101225_bib90","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8941471","article-title":"The role of MicroRNA in paediatric acute lymphoblastic leukaemia: challenges for diagnosis and therapy","volume":"2019","author":"Grobbelaar","year":"2019","journal-title":"J. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib91","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/1756-185X.13333","article-title":"CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis","volume":"21","author":"Gupta","year":"2018","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.drup.2025.101225_bib92","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.bbrc.2017.11.121","article-title":"Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c\/ABCB1 axis","volume":"495","author":"Han","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drup.2025.101225_bib93","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2340\/00015555-3155","article-title":"Clinical profile of methotrexate-resistant juvenile localised scleroderma","volume":"99","author":"Hardy","year":"2019","journal-title":"Acta Derm. -Venereol."},{"key":"10.1016\/j.drup.2025.101225_bib94","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2340\/00015555-3155","article-title":"Clinical profile of methotrexate-resistant juvenile localised scleroderma","volume":"99","author":"Hardy","year":"2019","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.drup.2025.101225_bib95","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1023\/A:1008381801403","article-title":"Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial","volume":"11","author":"Harrison","year":"2000","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib96","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jpeds.2013.10.029","article-title":"Methotrexate: new uses for an old drug","volume":"164","author":"Hashkes","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.drup.2025.101225_bib97","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s10147-019-01451-9","article-title":"Cell-type-specific sensitivity of bortezomib in the methotrexate-resistant primary central nervous system lymphoma cells","volume":"24","author":"Hayano","year":"2019","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib98","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/acr.20070","article-title":"Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland","volume":"62","author":"Herrick","year":"2010","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.drup.2025.101225_bib99","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/clinchem\/hvaa003","article-title":"Calibrating from within: multipoint internal calibration of a quantitative mass spectrometric assay of serum methotrexate","volume":"66","author":"Hoffman","year":"2020","journal-title":"Clin. Chem."},{"key":"10.1016\/j.drup.2025.101225_bib100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2125.2011.04054.x","article-title":"High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients","volume":"73","author":"Holmboe","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drup.2025.101225_bib101","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.drup.2025.101225_bib102","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2174\/1381612825666190329141003","article-title":"Methotrexate disposition in pediatric patients with acute lymphoblastic leukemia: what have we learnt from the genetic variants of drug transporters","volume":"25","author":"Hu","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.drup.2025.101225_bib103","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4161\/auto.8.2.18940","article-title":"Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma","volume":"8","author":"Huang","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2025.101225_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101082","article-title":"Advances in molecular targeted drugs in combination with CAR-T cell therapy for hematologic malignancies","author":"Huang","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.drup.2025.101225_bib105","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","article-title":"Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group","volume":"30","author":"Hunger","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib106","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/FPC.0000000000000245","article-title":"MiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia","volume":"26","author":"Iparraguirre","year":"2016","journal-title":"Pharm. Genom."},{"key":"10.1016\/j.drup.2025.101225_bib107","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1200\/JCO.2014.59.4895","article-title":"Osteosarcoma: current treatment and a collaborative pathway to success","volume":"33","author":"Isakoff","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib108","doi-asserted-by":"crossref","first-page":"305","DOI":"10.18433\/jpps29496","article-title":"In vitro-and in vivo evaluation of methotrexate-loaded hydrogel nanoparticles intended to treat primary CNS lymphoma via intranasal administration","volume":"21","author":"Jahromi","year":"2018","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.drup.2025.101225_bib109","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ijbiomac.2018.12.093","article-title":"A mechanistic investigation on methotrexate-loaded chitosan-based hydrogel nanoparticles intended for CNS drug delivery: Trojan horse effect or not?","volume":"125","author":"Jahromi","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.drup.2025.101225_bib110","article-title":"Preparation and in vitro\/in vivo characterization of polymeric nanoparticles containing methotrexate to improve lymphatic delivery","author":"Jang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2025.101225_bib111","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.leukres.2019.02.008","article-title":"Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation","volume":"79","author":"Jaramillo","year":"2019","journal-title":"Leuk. Res."},{"key":"10.1016\/j.drup.2025.101225_bib112","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.3390\/ijms23063067","article-title":"Resistance mechanisms in pediatric B-cell acute lymphoblastic leukemia","volume":"23","author":"J\u0119draszek","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2025.101225_bib113","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1200\/JCO.19.01692","article-title":"Improved CNS control of childhood acute lymphoblastic leukemia without cranial irradiation: St Jude Total Therapy Study 16","volume":"37","author":"Jeha","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib114","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.3892\/ol.2015.3790","article-title":"MicroRNA-126 enhances the sensitivity of osteosarcoma cells to cisplatin and methotrexate","volume":"10","author":"Jiang","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.drup.2025.101225_bib115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1389200224666230406120714","article-title":"Evaluation of intracellular metabolism of methotrexate in hepatocytes and embryonic kidney cells based on folylpolyglutamate synthetase and gamma-glutamyl hydrolase expression","volume":"24","author":"Jiang","year":"2023","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.drup.2025.101225_bib116","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1172\/JCI22477","article-title":"Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics","volume":"115","author":"Kager","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.drup.2025.101225_bib117","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41586-018-0316-7","article-title":"Histidine catabolism is a major determinant of methotrexate sensitivity","volume":"559","author":"Kanarek","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101225_bib118","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/hematolrep15040065","article-title":"Association of microRNA polymorphisms with toxicities induced by methotrexate in children with acute lymphoblastic leukemia","volume":"15","author":"Karpa","year":"2023","journal-title":"Hematol. Rep."},{"key":"10.1016\/j.drup.2025.101225_bib119","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1182\/blood.2020005026","article-title":"Prediction and prevention of central nervous system relapse in patients with extranodal natural killer\/T-cell lymphoma","volume":"136","author":"Kim","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.drup.2025.101225_bib120","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/annonc\/mdn551","article-title":"Effective second-line chemotherapy for extranodal NK\/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone","volume":"20","author":"Kim","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib121","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1200\/JCO.2009.22.2950","article-title":"Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia consortium study","volume":"28","author":"Ko","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib122","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00228-013-1623-4","article-title":"Pharmacogenetics of methotrexate in acute lymphoblastic leukaemia: why still at the bench level?","volume":"70","author":"Kodidela","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.drup.2025.101225_bib123","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc1692","article-title":"The role of autophagy in cancer development and response to therapy","volume":"5","author":"Kondo","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib124","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1532\/IJH97.E0624","article-title":"Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia","volume":"86","author":"Kourti","year":"2007","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.drup.2025.101225_bib125","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.drup.2025.101225_bib126","doi-asserted-by":"crossref","DOI":"10.3390\/futurepharmacol3040049","article-title":"Erythrocyte folyl polyglutamate synthetase activity profiling as a potential tool for the prediction of methotrexate efficacy and toxicity in rheumatoid arthritis","volume":"3","author":"Kumar","year":"2023","journal-title":"Future Pharmacol."},{"key":"10.1016\/j.drup.2025.101225_bib127","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1600-065X.2009.00829.x","article-title":"The T-cell-specific adapter protein family: TSAd, ALX, and SH2D4A\/SH2D4B","volume":"232","author":"Lapinski","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.drup.2025.101225_bib128","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1200\/JCO.2005.11.075","article-title":"Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial","volume":"23","author":"Laver","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib129","first-page":"3832","article-title":"Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia","volume":"100","author":"Laverdiere","year":"2002","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.drup.2025.101225_bib130","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2141.2000.01891.x","article-title":"Darbyshire and m.c.l.w. party, The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study","volume":"108","author":"Lawson","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.drup.2025.101225_bib131","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/imr.12793","article-title":"Cellular therapy: adoptive immunotherapy with expanded natural killer cells","volume":"290","author":"Lee","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.drup.2025.101225_bib132","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.pcl.2018.04.002","article-title":"Scleroderma in children and adolescents: localized scleroderma and systemic sclerosis","volume":"65","author":"Li","year":"2018","journal-title":"Pedia Clin. North Am."},{"key":"10.1016\/j.drup.2025.101225_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101141","article-title":"Folylpolyglutamate synthetase inactivation in relapsed ALL induces a druggable folate metabolic vulnerability","volume":"77","author":"Li","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.drup.2025.101225_bib134","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.omtn.2022.01.015","article-title":"lncNBAT1\/APOBEC3A is a mediator of HBX-induced chemoresistance in diffuse large B cell lymphoma cells","volume":"27","author":"Li","year":"2022","journal-title":"Mol. Ther. -Nucleic Acids"},{"key":"10.1016\/j.drup.2025.101225_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-8722-6-19","article-title":"Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers","volume":"6","author":"Li","year":"2013","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib136","article-title":"Emerging advances in drug delivery systems (DDSs) for optimising cancer complications","author":"Li","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.drup.2025.101225_bib137","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1021\/acs.biochem.1c00558","article-title":"Evolution of optimized hydride transfer reaction and overall enzyme turnover in human dihydrofolate reductase","volume":"60","author":"Li","year":"2021","journal-title":"Biochemistry"},{"key":"10.1016\/j.drup.2025.101225_bib138","doi-asserted-by":"crossref","first-page":"14157","DOI":"10.18632\/aging.103423","article-title":"Circular RNA hsa_circ_0000073 contributes to osteosarcoma cell proliferation, migration, invasion and methotrexate resistance by sponging miR-145-5p and miR-151-3p and upregulating NRAS","volume":"12","author":"Li","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.drup.2025.101225_bib139","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/ijc.10829","article-title":"Loss of folylpoly-\u03b3-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines","volume":"103","author":"Liani","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib140","first-page":"524","article-title":"Efficacy and safety of intensive maintenance chemotherapy regimen for treatment of children and adolescents with lymphoblastic lymphoma for stage III-IV","volume":"28","author":"Liu","year":"2020","journal-title":"Zhongguo shi yan xue ye xue za zhi"},{"key":"10.1016\/j.drup.2025.101225_bib141","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2023.05.040","article-title":"Cerebral delivery of redox-responsive lenalidomide prodrug plus methotrexate for primary central nerve system lymphoma combination therapy","volume":"359","author":"Liu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drup.2025.101225_bib142","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cancergen.2023.10.001","article-title":"Pan-cancer genetic analysis of disulfidptosis-related gene set","volume":"278","author":"Liu","year":"2023","journal-title":"Cancer Genet."},{"key":"10.1016\/j.drup.2025.101225_bib143","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1200\/JCO.2013.54.5020","article-title":"Triple intrathecal therapy alone with omission of cranial radiation in children with acute lymphoblastic leukemia","volume":"32","author":"Liu","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-01364-y","article-title":"\u03b2-catenin promotes MTX resistance of leukemia cells by down-regulating FPGS expression via NF-\u03baB","volume":"20","author":"Liu","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.drup.2025.101225_bib145","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41572-022-00404-3","article-title":"Burkitt lymphoma","volume":"8","author":"L\u00f3pez","year":"2022","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.drup.2025.101225_bib146","doi-asserted-by":"crossref","first-page":"7342","DOI":"10.1038\/s41598-018-25634-y","article-title":"Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis","volume":"8","author":"L\u00f3pez-Rodr\u00edguez","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2025.101225_bib147","first-page":"615","article-title":"Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. Cancer Discov. 2014; 4: 889\u2013895. doi: 10.1158\/2159-8290","volume":"88","author":"Lovly","year":"1987","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.drup.2025.101225_bib148","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/2159-8290.CD-14-0377","article-title":"Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions","volume":"4","author":"Lovly","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.drup.2025.101225_bib149","first-page":"1","article-title":"Cells and signals of the leukemic microenvironment that support progression of T-cell acute lymphoblastic leukemia (T-ALL)","author":"Lyu","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.drup.2025.101225_bib150","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.molcel.2015.12.014","article-title":"Serine metabolism supports the methionine cycle and DNA\/RNA methylation through de novo ATP synthesis in cancer cells","volume":"61","author":"Maddocks","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drup.2025.101225_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2021.100768","article-title":"Inflammatory myofibroblastic tumor: molecular landscape, targeted therapeutics, and remaining challenges","volume":"45","author":"Mahajan","year":"2021","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib152","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-1-4939-8982-9_10","article-title":"Noncoding RNAs databases: current status and trends","volume":"1912","author":"Maracaja-Coutinho","year":"2019","journal-title":"Methods Mol. Biol. (Clifton, NJ)"},{"key":"10.1016\/j.drup.2025.101225_bib153","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-021-00332-8","article-title":"Juvenile idiopathic arthritis","volume":"8","author":"Martini","year":"2022","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.drup.2025.101225_bib154","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1215\/S1152851704000304","article-title":"Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma","volume":"7","author":"Massimino","year":"2005","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib155","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0021-9258(19)75842-6","article-title":"The effects on 4-aminoantifolates on 5-formyltetrahydrofolate metabolism in L1210 cells. A biochemical basis of the selectivity of leucovorin rescue","volume":"262","author":"Matherly","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2025.101225_bib156","first-page":"578","article-title":"Increased frequency of expression of elevated dihydrofolate reductase in T-cell versus B-precursor acute lymphoblastic leukemia in children","volume":"90","author":"Matherly","year":"1997","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"10.1016\/j.drup.2025.101225_bib157","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nrc3673","article-title":"Directed development","volume":"14","author":"McCarthy","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib158","doi-asserted-by":"crossref","DOI":"10.5812\/ijcm.93300","article-title":"Gene Expression of ABCG1, ABCG2, and ABCB1 and Their Role in Iranian Pediatric Patients with Acute Lymphoblastic Leukemia\u2019s Recurrence","volume":"12","author":"Mehrvar","year":"2019","journal-title":"Int. J. Cancer Manag."},{"key":"10.1016\/j.drup.2025.101225_bib159","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10787-021-00921-9","article-title":"Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study","volume":"30","author":"Melikoglu","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.drup.2025.101225_bib160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000203749","article-title":"Treatment of acute leukemia with amethopterin (4-amino, 10-methyl pteroyl glutamic acid)","volume":"4","author":"Meyer","year":"1950","journal-title":"Acta Haematol."},{"key":"10.1016\/j.drup.2025.101225_bib161","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1158\/0008-5472.CAN-08-1856","article-title":"Reversal of P-glycoprotein\u2013mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3","volume":"69","author":"Michaelis","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101225_bib162","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.acr.2014.10.002","article-title":"Regulation of ABC transporters blood\u2013brain barrier: the good, the bad, and the ugly","volume":"125","author":"Miller","year":"2015","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.drup.2025.101225_bib163","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1915315","article-title":"Rituximab for high-risk, mature B-cell non-Hodgkin's lymphoma in children","volume":"382","author":"Minard-Colin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101225_bib164","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","article-title":"Methods in mammalian autophagy research","volume":"140","author":"Mizushima","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.drup.2025.101225_bib165","first-page":"1","article-title":"Human ABCG2: structure, function, and its role in multidrug resistance","volume":"3","author":"Mo","year":"2012","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"10.1016\/j.drup.2025.101225_bib166","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186847","article-title":"Methrotexate treatment inmunomodulates abnormal cytokine expression by T CD4 lymphocytes present in DMARD-Na\u00efve Rheumatoid Arthritis Patients","volume":"21","author":"Monserrat Sanz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.drup.2025.101225_bib167","first-page":"2101","article-title":"Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000","volume":"127","author":"M\u00f6ricke","year":"2016","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.drup.2025.101225_bib168","doi-asserted-by":"crossref","first-page":"1280587","DOI":"10.3389\/fonc.2023.1280587","article-title":"Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients","volume":"13","author":"Mosleh","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib169","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/ph5080802","article-title":"Involvement of multiple transporters-mediated transports in mizoribine and methotrexate pharmacokinetics","volume":"5","author":"Murakami","year":"2012","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.drup.2025.101225_bib170","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.3390\/cancers14205127","article-title":"Association between dysfunction of the nucleolar stress response and multidrug resistance in pediatric acute lymphoblastic leukemia","volume":"14","author":"Nakagawa","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2025.101225_bib171","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.chom.2020.12.008","article-title":"Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation","volume":"29","author":"Nayak","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.drup.2025.101225_bib172","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41375-021-01444-6","article-title":"Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma","volume":"36","author":"Newman","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.drup.2025.101225_bib173","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.218","article-title":"Metabolic reprogramming in cancer: mechanisms and therapeutics","volume":"4","author":"Nong","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.drup.2025.101225_bib174","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1006\/bbrc.2001.5890","article-title":"HSH2: a novel SH2 domain-containing adapter protein involved in tyrosine kinase signaling in hematopoietic cells","volume":"288","author":"Oda","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drup.2025.101225_bib175","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41408-021-00535-y","article-title":"High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphoma","volume":"11","author":"Ong","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.drup.2025.101225_bib176","first-page":"413","article-title":"Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions","volume":"139","author":"Orellana-Noia","year":"2022","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"10.1016\/j.drup.2025.101225_bib177","first-page":"8405","article-title":"Overexpression of dihydrofolate reductase is a factor of poor survival in acute lymphoblastic leukemia","volume":"15","author":"Organista Nava","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.drup.2025.101225_bib178","first-page":"8405","article-title":"Overexpression of dihydrofolate reductase is a factor of poor survival in acute lymphoblastic leukemia","volume":"15","author":"Organista\u2011Nava","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.drup.2025.101225_bib179","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s43018-020-00124-1","article-title":"Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia","volume":"1","author":"Oshima","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib180","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/bcp.14160","article-title":"Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumours","volume":"86","author":"Panetta","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drup.2025.101225_bib181","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/bcp.14160","article-title":"Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumours","volume":"86","author":"Panetta","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drup.2025.101225_bib182","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3390\/cancers13071536","article-title":"Mechanisms of immune evasion in acute lymphoblastic leukemia","volume":"13","author":"Pastorczak","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2025.101225_bib183","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/leu.2014.215","article-title":"IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia","volume":"29","author":"Pegram","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.drup.2025.101225_bib184","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaut.2018.01.004","article-title":"TGF-\u03b2 signalling defect is linked to low CD39 expression on regulatory T cells and methotrexate resistance in rheumatoid arthritis","volume":"90","author":"Peres","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.drup.2025.101225_bib185","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.1424792112","article-title":"Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis","volume":"112","author":"Peres","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.drup.2025.101225_bib186","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.bjp.0705054","article-title":"The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species","volume":"138","author":"Phillips","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drup.2025.101225_bib187","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1200\/JCO.2015.64.6364","article-title":"Successful therapy reduction and intensification for childhood acute lymphoblastic leukemia based on minimal residual disease monitoring: study ALL10 from the Dutch Childhood Oncology Group","volume":"34","author":"Pieters","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib188","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29460","article-title":"Clinical, pathologic, and molecular features of inflammatory myofibroblastic tumors in children and adolescents","volume":"69","author":"Pire","year":"2022","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib189","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation","volume":"360","author":"Pui","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drup.2025.101225_bib190","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00432-019-02949-5","article-title":"Ginger extract has anti-leukemia and anti-drug resistant effects on malignant cells","volume":"145","author":"Rahimi","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib191","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11912-013-0321-9","article-title":"The adolescent and young adult with cancer: State of the art-bone tumors","volume":"15","author":"Rainusso","year":"2013","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.drup.2025.101225_bib192","first-page":"1","article-title":"orbin-Kon, plasma distribution of methotrexate and its polyglutamates in pediatric acute lymphoblastic leukemia: preliminary insights","author":"Raj\u0161i\u0107","year":"2022","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.drup.2025.101225_bib193","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/gtmb.2015.0287","article-title":"Mexican childhood acute lymphoblastic leukemia: a pilot study of the MDR1 and MTHFR gene polymorphisms and their associations with clinical outcomes","volume":"20","author":"Ram\u00edrez-Pacheco","year":"2016","journal-title":"Genet. Test. Mol. Biomark."},{"key":"10.1016\/j.drup.2025.101225_bib194","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-018-1620-6","article-title":"Effect of metformin on the survival of patients with ALL who express high levels of the ABCB1 drug resistance gene","volume":"16","author":"Ramos-Pe\u00f1afiel","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.drup.2025.101225_bib195","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1021\/jm501535r","article-title":"CNS drug design: balancing physicochemical properties for optimal brain exposure","volume":"58","author":"Rankovic","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drup.2025.101225_bib196","first-page":"3294","article-title":"Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-M\u00fcnster Group Trial NHL-BFM 90","volume":"94","author":"Reiter","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.drup.2025.101225_bib197","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2015.04.014","article-title":"A micelle-like structure of poloxamer\u2013methotrexate conjugates as nanocarrier for methotrexate delivery","volume":"487","author":"Ren","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drup.2025.101225_bib198","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/ijc.34132","article-title":"Inflammatory myofibroblastic tumor: a multi-institutional study from the pediatric surgical oncology research collaborative","volume":"151","author":"Rich","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib199","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrclinonc.2015.38","article-title":"Genomics in acute lymphoblastic leukaemia: insights and treatment implications","volume":"12","author":"Roberts","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib200","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib201","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.gpb.2016.11.003","article-title":"The promise of pharmacogenomics in reducing toxicity during acute lymphoblastic leukemia maintenance treatment","volume":"15","author":"Rudin","year":"2017","journal-title":"Genom. Proteom. Bioinforma."},{"key":"10.1016\/j.drup.2025.101225_bib202","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrc2867","article-title":"Genetic variation in microRNA networks: the implications for cancer research","volume":"10","author":"Ryan","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib203","first-page":"83","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview","volume":"102","author":"Sabattini","year":"2010","journal-title":"Pathologica"},{"key":"10.1016\/j.drup.2025.101225_bib204","doi-asserted-by":"crossref","first-page":"10290","DOI":"10.1038\/s41598-019-46700-z","article-title":"A role for ABCB1 in prognosis, invasion and drug resistance in ependymoma","volume":"9","author":"Sabnis","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2025.101225_bib205","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/leu.2017.283","article-title":"High-dose methotrexate therapy significantly improved survival of adult acute lymphoblastic leukemia: a phase III study by JALSG","volume":"32","author":"Sakura","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.drup.2025.101225_bib206","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4103\/1735-5362.378085","article-title":"The effects of Astragalus polysaccharides, tragacanthin, and bassorin on methotrexate-resistant acute lymphoblastic leukemia","volume":"18","author":"Samii","year":"2023","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.drup.2025.101225_bib207","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MPH.0b013e31829d4900","article-title":"Therapy of advanced-stage mature B-cell lymphoma and leukemia in children and adolescents with rituximab and reduced intensity induction chemotherapy (B-NHL 2004M protocol): the results of a multicenter study","volume":"36","author":"Samochatova","year":"2014","journal-title":"J. Pediatr. Hematol. \/Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib208","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/bcmd.2000.0372","article-title":"Bcl-2 mediates chemoresistance in matched pairs of primary E(mu)-myc lymphomas in vivo","volume":"27","author":"Schmitt","year":"2001","journal-title":"Blood Cells Olecules Dis."},{"key":"10.1016\/j.drup.2025.101225_bib209","article-title":"Inflammatory myofibroblastic tumor with ROS1 gene fusions in children and young adolescents","volume":"7","author":"Schoot","year":"2023","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib210","first-page":"3699","article-title":"Short-pulse B\u2013non-Hodgkin lymphoma\u2013type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90","volume":"97","author":"Seidemann","year":"2001","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.drup.2025.101225_bib211","doi-asserted-by":"crossref","first-page":"40647","DOI":"10.1074\/jbc.M404198200","article-title":"The ALX Src homology 2 domain is both necessary and sufficient to inhibit T cell receptor\/CD28-mediated up-regulation of RE\/AP","volume":"279","author":"Shapiro","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2025.101225_bib212","series-title":"Antifolate Drugs in Cancer Therapy","first-page":"183","article-title":"Preclinical pharmacology studies and the clinical development of a novel multitargeted antifolate, MTA (LY231514)","author":"Shih","year":"1999"},{"key":"10.1016\/j.drup.2025.101225_bib213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-018-0522-4","article-title":"Clinical significance of polyglutamylation in primary central nervous system lymphoma","volume":"6","author":"Shinojima","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.drup.2025.101225_bib214","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/art.41223","article-title":"Association of a type 2-polarized t cell phenotype with methotrexate nonresponse in patients with rheumatoid arthritis","volume":"72","author":"Slauenwhite","year":"2020","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.drup.2025.101225_bib215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-9-96","article-title":"Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells","volume":"9","author":"Song","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib216","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1038\/onc.2009.274","article-title":"Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells","volume":"28","author":"Song","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2025.101225_bib217","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bjo.76.11.670","article-title":"A new local anesthesia technique for cataract extraction by one quadrant sub-Tenon's infiltration","volume":"76","author":"Stevens","year":"1992","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.drup.2025.101225_bib218","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1158\/0008-5472.CAN-06-3254","article-title":"The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines","volume":"67","author":"Strauss","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101225_bib219","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1158\/0008-5472.CAN-06-3254","article-title":"The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines","volume":"67","author":"Strauss","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101225_bib220","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/CAD.0000000000001099","article-title":"Therapeutic options in inoperable ROS1-rearranged inflammatory myofibroblastic tumor of the tongue in a child: a case report and literature review","volume":"32","author":"Styczewska","year":"2021","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.drup.2025.101225_bib221","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164778","article-title":"TAp63, a methotrexate target in CD4+\u2009T cells, suppresses Foxp3 expression and exacerbates autoimmune arthritis","volume":"8","author":"Suga","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.drup.2025.101225_bib222","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1038\/s41375-018-0094-0","article-title":"Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study","volume":"32","author":"Sun","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.drup.2025.101225_bib223","first-page":"2754","article-title":"Metabolome analysis reveals excessive glycolysis via PI3K\/AKT\/MTOR and RAS\/MAPK signaling in methotrexate-resistant primary CNS lymphoma\u2013derived cells","volume":"26","author":"Takashima","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101225_bib224","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/nar\/13.6.2035","article-title":"Nucleotide sequence of a functional cDNA for human thymidylate synthase","volume":"13","author":"Takeishi","year":"1985","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.drup.2025.101225_bib225","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1200\/JCO.2009.25.1983","article-title":"Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90","volume":"28","author":"Tallen","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-020-01524-0","article-title":"Association of relapse-linked ARID5B single nucleotide polymorphisms with drug resistance in B-cell precursor acute lymphoblastic leukemia cell lines","volume":"20","author":"Tamai","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.drup.2025.101225_bib227","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1042\/bse0500209","article-title":"The controversial role of ABC transporters in clinical oncology","volume":"50","author":"Tamaki","year":"2011","journal-title":"Essays Biochem."},{"key":"10.1016\/j.drup.2025.101225_bib228","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/pbc.21629","article-title":"Long-term outcome of childhood acute lymphoblastic leukemia treated in China","volume":"51","author":"Tang","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib229","first-page":"331","article-title":"Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation","volume":"138","author":"Tang","year":"2021","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.drup.2025.101225_bib230","article-title":"Cellular pharmacokinetic of methotrexate and its modulation by folylpolyglutamate synthetase and \u03b3-glutamyl hydrolase in tumor cells","volume":"19","author":"Tang","year":"2024","journal-title":"Plos One"},{"key":"10.1016\/j.drup.2025.101225_bib231","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00280-017-3340-7","article-title":"ABCC4 functional SNP in the 3\u2032 splice acceptor site of exon 8 (G912T) is associated with unfavorable clinical outcome in children with acute lymphoblastic leukemia","volume":"80","author":"Tanha","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.drup.2025.101225_bib232","first-page":"528","article-title":"Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients","volume":"18","author":"Taylor","year":"2018","journal-title":"Pharm. J."},{"key":"10.1016\/j.drup.2025.101225_bib233","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.3390\/cancers13112837","article-title":"Systematic review of pharmacogenetic factors that influence high-dose methotrexate pharmacokinetics in pediatric malignancies","volume":"13","author":"Taylor","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.drup.2025.101225_bib234","first-page":"2020","article-title":"mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia","volume":"112","author":"Teachey","year":"2008","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.drup.2025.101225_bib235","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/leu.2017.265","article-title":"Results of NOPHO ALL2008 treatment for patients aged 1\u201345 years with acute lymphoblastic leukemia","volume":"32","author":"Toft","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.drup.2025.101225_bib236","first-page":"5317","article-title":"Regulations of ABCB1 and ABCG2 expression through MAPK pathways in acute lymphoblastic leukemia cell lines","volume":"33","author":"Tomiyasu","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.drup.2025.101225_bib237","first-page":"1161","article-title":"Effects of germline DHFR and FPGS variants on methotrexate metabolism and relapse of leukemia","volume":"136","author":"Tulstrup","year":"2020","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.drup.2025.101225_bib238","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113666","article-title":"Methotrexate significantly induces apoptosis by inhibiting STAT3 activation in NPM-ALK-positive ALCL cells","volume":"170","author":"Uchihara","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.drup.2025.101225_bib239","first-page":"735","article-title":"Biology and treatment of childhood T-lineage acute lymphoblastic leukemia","volume":"91","author":"Uckun","year":"1998","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.drup.2025.101225_bib240","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1111\/j.1349-7006.2010.01690.x","article-title":"ABCC11\/MRP8 confers pemetrexed resistance in lung cancer","volume":"101","author":"Uemura","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.drup.2025.101225_bib241","doi-asserted-by":"crossref","first-page":"177","DOI":"10.18585\/inabj.v12i2.1109","article-title":"MTHFR C677T and TS 5\u2019-UTR 3R\/3R gene polymorphism in methotrexate-resistant childhood acute lymphoblastic leukemia","volume":"12","author":"Ugrasena","year":"2020","journal-title":"Indones. Biomed. J."},{"key":"10.1016\/j.drup.2025.101225_bib242","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2217\/pgs-2017-0164","article-title":"Role of miRNAs in treatment response and toxicity of childhood acute lymphoblastic leukemia","volume":"19","author":"Umerez","year":"2018","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.drup.2025.101225_bib243","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/ncprheum0380","article-title":"Drug insight: resistance to methotrexate and other disease-modifying antirheumatic drugs\u2014from bench to bedside","volume":"3","author":"Van Der Heijden","year":"2007","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.drup.2025.101225_bib244","first-page":"5538","article-title":"Wild-type breast cancer resistance protein (BCRP\/ABCG2) is a methotrexate polyglutamate transporter","volume":"63","author":"Volk","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101225_bib245","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1470-2045(12)70600-9","article-title":"Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial","volume":"14","author":"Vora","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib246","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1182\/bloodadvances.2018016584","article-title":"Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001","volume":"2","author":"Vrooman","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.drup.2025.101225_bib247","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10637-005-4541-1","article-title":"From methotrexate to pemetrexed and beyond. A review of the pharmacodynamic and clinical properties of antifolates","volume":"24","author":"Walling","year":"2006","journal-title":"Investig. N. Drugs"},{"key":"10.1016\/j.drup.2025.101225_bib248","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/1873-3468.14285","article-title":"A \u03b3-glutamyl hydrolase lacking the signal peptide confers susceptibility to folates\/antifolates in acute lymphoblastic leukemia cells","volume":"596","author":"Wang","year":"2022","journal-title":"FEBS Lett."},{"key":"10.1016\/j.drup.2025.101225_bib249","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-018-0554-z","article-title":"Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells","volume":"11","author":"Wang","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib250","first-page":"2121","article-title":"HSH2D contributes to methotrexate resistance in human T\u2011cell acute lymphoblastic leukaemia","volume":"44","author":"Wang","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.drup.2025.101225_bib251","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.leukres.2018.01.004","article-title":"Association between a microRNA binding site polymorphism in\u00a0SLCO1A2\u00a0and the risk of delayed methotrexate elimination in Chinese children with acute lymphoblastic leukemia","volume":"65","author":"Wang","year":"2018","journal-title":"Leuk. Res."},{"key":"10.1016\/j.drup.2025.101225_bib252","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1586\/14737140.9.3.331","article-title":"Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy","volume":"9","author":"Webb","year":"2009","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.drup.2025.101225_bib253","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/(SICI)1096-911X(200002)34:2<143::AID-MPO15>3.0.CO;2-1","article-title":"High-dose intense chemotherapy in South African children with B-cell lymphoma: morbidity, supportive measures, and outcome","volume":"34","author":"Wessels","year":"2000","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib254","first-page":"3795","article-title":"Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein","volume":"55","author":"Westerhof","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101225_bib255","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrc3262","article-title":"Deconvoluting the context-dependent role for autophagy in cancer","volume":"12","author":"White","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib256","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29901","article-title":"Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR)","volume":"69","author":"Whitlock","year":"2022","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib257","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1158\/0008-5472.CAN-04-2810","article-title":"The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates","volume":"65","author":"Wielinga","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.drup.2025.101225_bib258","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2004-03-0973","article-title":"The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95","volume":"105","author":"Woessmann","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.drup.2025.101225_bib259","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2016.142794","article-title":"The association of aberrant folylpolyglutamate synthetase splicing with ex vivo methotrexate resistance and clinical outcome in childhood acute lymphoblastic leukemia","volume":"101","author":"Wojtuszkiewicz","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.drup.2025.101225_bib260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-015-0158-9","article-title":"Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia","volume":"8","author":"Wojtuszkiewicz","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib261","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/ijc.29919","article-title":"Folylpolyglutamate synthetase splicing alterations in acute lymphoblastic leukemia are provoked by methotrexate and other chemotherapeutics and mediate chemoresistance","volume":"138","author":"Wojtuszkiewicz","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib262","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/pbc.22940","article-title":"and N.H.L. European Inter-Group for Childhood, Safety assessment of intensive induction therapy in childhood anaplastic large cell lymphoma: report of the ALCL99 randomised trial","volume":"56","author":"Wrobel","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib263","first-page":"5240","article-title":"BCL6 promotes the methotrexate-resistance by upregulating ZEB1 expression in children with acute B lymphocytic leukemia","volume":"22","author":"Wu","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.drup.2025.101225_bib264","article-title":"BCL6 promotes the methotrexate-resistance by upregulating ZEB1 expression in children with acute B lymphocytic leukemia","volume":"22","author":"Wu","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.drup.2025.101225_bib265","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.biopha.2018.06.015","article-title":"The effects of DMARDs on the expression and function of P-gp, MRPs, BCRP in the treatment of autoimmune diseases","volume":"105","author":"Wu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.drup.2025.101225_bib266","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-018-0880-6","article-title":"HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma","volume":"37","author":"Xiao","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101225_bib267","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/ijc.34465","article-title":"Absence of terminal deoxynucleotidyl transferase expression in T-ALL\/LBL accumulates chromosomal abnormalities to induce drug resistance","volume":"152","author":"Xiao","year":"2023","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib268","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3389\/fphar.2019.01072","article-title":"Intracranial hemorrhage following oral low-dose methotrexate after multiple toxicities caused by high-dose methotrexate in childhood acute lymphoblastic leukemia","volume":"10","author":"Xin","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.drup.2025.101225_bib269","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110141","article-title":"The multiple function of long noncoding RNAs in osteosarcoma progression, drug resistance and prognosis","volume":"127","author":"Xu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.drup.2025.101225_bib270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-014-0972-x","article-title":"MiR-34c inhibits osteosarcoma metastasis and chemoresistance","volume":"31","author":"Xu","year":"2014","journal-title":"Med. Oncol."},{"key":"10.1016\/j.drup.2025.101225_bib271","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.18632\/oncotarget.2418","article-title":"miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma","volume":"5","author":"Xu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.drup.2025.101225_bib272","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.12659\/MSM.911972","article-title":"miR-29 family inhibits resistance to methotrexate and promotes cell apoptosis by targeting COL3A1 and MCL1 in osteosarcoma","volume":"24","author":"Xu","year":"2018","journal-title":"Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.drup.2025.101225_bib273","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1158\/1078-0432.CCR-19-0190","article-title":"ARID5B influences antimetabolite drug sensitivity and prognosis of acute lymphoblastic leukemia","volume":"26","author":"Xu","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.drup.2025.101225_bib274","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3892\/or.2015.4393","article-title":"miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3","volume":"35","author":"Xu","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.drup.2025.101225_bib275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.789334","article-title":"Pharmacomicrobiology of methotrexate in rheumatoid arthritis: gut microbiome as predictor of therapeutic response","volume":"12","author":"Yan","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drup.2025.101225_bib276","first-page":"211","article-title":"Progress in research on the mechanism of drug resistance to conventional chemotherapeutic drugs in children with acute lymphoblastic leukemia","volume":"42","author":"Yanyan","year":"2022","journal-title":"J. Shanghai Jiaotong Univ. (Med. Sci. )"},{"key":"10.1016\/j.drup.2025.101225_bib277","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.xphs.2015.11.031","article-title":"Increased systemic exposure of methotrexate by a polyphenol-rich herb via modulation on efflux transporters multidrug resistance\u2013associated protein 2 and breast cancer resistance protein","volume":"105","author":"Yu","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drup.2025.101225_bib278","doi-asserted-by":"crossref","first-page":"12074","DOI":"10.1038\/s41598-020-69059-y","article-title":"FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemia","volume":"10","author":"Yu","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2025.101225_bib279","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10787-020-00741-3","article-title":"The advances of methotrexate resistance in rheumatoid arthritis","volume":"28","author":"Yu","year":"2020","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.drup.2025.101225_bib280","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3899\/jrheum.160950","article-title":"Relationship between polymorphisms in methotrexate pathway genes and outcome of methotrexate treatment in a cohort of 119 patients with juvenile idiopathic arthritis","volume":"44","author":"Zajc Avramovi\u010d","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.drup.2025.101225_bib281","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001419","article-title":"Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity","volume":"8","author":"Zanetti","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.drup.2025.101225_bib282","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12969-021-00629-8","article-title":"Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches","volume":"19","author":"Zaripova","year":"2021","journal-title":"Pedia Rheuma Online J."},{"key":"10.1016\/j.drup.2025.101225_bib283","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1182\/blood-2005-01-0143","article-title":"Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment","volume":"106","author":"Zaza","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.drup.2025.101225_bib284","first-page":"2169","article-title":"Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy","volume":"4","author":"Zhang","year":"1998","journal-title":"Clin. Cancer Res.: Official J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.drup.2025.101225_bib285","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1038\/sj.onc.1206946","article-title":"Resistance to antifolates","volume":"22","author":"Zhao","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.drup.2025.101225_bib286","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41419-017-0097-1","article-title":"HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphoma","volume":"9","author":"Zhao","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101225_bib287","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113074","article-title":"Application and pharmacological mechanism of methotrexate in rheumatoid arthritis","volume":"150","author":"Zhao","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.drup.2025.101225_bib288","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/jnci\/djac101","article-title":"Molecular mechanisms of ARID5B-mediated genetic susceptibility to acute lymphoblastic leukemia","volume":"114","author":"Zhao","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.drup.2025.101225_bib289","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.20181965","article-title":"Toward a better understanding of folate metabolism in health and disease","volume":"216","author":"Zheng","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drup.2025.101225_bib290","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/aps.2015.153","article-title":"Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression","volume":"37","author":"Zhou","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.drup.2025.101225_bib291","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/ejh.14006","article-title":"Augmenter of liver regeneration promotes drug resistance of acute lymphoblastic leukemia through the alteration of mitochondrial functions and the inhibition of the mitochondrial apoptosis pathway","volume":"111","author":"Zhou","year":"2023","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.drup.2025.101225_bib292","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2217\/epi-2018-0023","article-title":"Screening circular RNA related to chemotherapeutic resistance in osteosarcoma by RNA sequencing","volume":"10","author":"Zhu","year":"2018","journal-title":"Epigenomics"},{"key":"10.1016\/j.drup.2025.101225_bib293","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.berh.2018.02.004","article-title":"Scleroderma in children","volume":"31","author":"Zulian","year":"2017","journal-title":"Best. Pract. Res. Clin. Rheuma"},{"key":"10.1016\/j.drup.2025.101225_bib294","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.30264","article-title":"Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial","volume":"63","author":"Zulian","year":"2011","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.drup.2025.101225_bib295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11926-020-00910-x","article-title":"Treatment in Juvenile Scleroderma","volume":"22","author":"Zulian","year":"2020","journal-title":"Curr. Rheumatol. Rep."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625000251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625000251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:27:47Z","timestamp":1762374467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764625000251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":295,"alternative-id":["S1368764625000251"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2025.101225","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methotrexate resistance and its regulatory mechanisms in pediatric tumors and beyond","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2025.101225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101225"}}